Follow this preprint
Large-scale study of antibody titer decay following BNT162b2 mRNA vaccine or SARS-CoV-2 infection
View ORCID ProfileAriel Israel, Yotam Shenhar, Ilan Green, View ORCID ProfileEugene Merzon, Avivit Golan-Cohen, View ORCID ProfileAlejandro A Schäffer, View ORCID ProfileEytan Ruppin, View ORCID ProfileShlomo Vinker, View ORCID ProfileEli Magen
doi: https://doi.org/10.1101/2021.08.19.21262111
Now published in Vaccines doi: 10.3390/vaccines10010064
Ariel Israel
1Leumit Research Institute & Department of Family Medicine, Leumit Health Services, Israel
MD, PhDYotam Shenhar
1Leumit Research Institute & Department of Family Medicine, Leumit Health Services, Israel
MDIlan Green
1Leumit Research Institute & Department of Family Medicine, Leumit Health Services, Israel
2Department of Family Medicine, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
MDEugene Merzon
1Leumit Research Institute & Department of Family Medicine, Leumit Health Services, Israel
2Department of Family Medicine, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
MDAvivit Golan-Cohen
1Leumit Research Institute & Department of Family Medicine, Leumit Health Services, Israel
2Department of Family Medicine, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
MDAlejandro A Schäffer
3Cancer Data Science Laboratory, National Cancer Institute, Bethesda, MD USA
PhDEytan Ruppin
3Cancer Data Science Laboratory, National Cancer Institute, Bethesda, MD USA
MD, PhDShlomo Vinker
1Leumit Research Institute & Department of Family Medicine, Leumit Health Services, Israel
2Department of Family Medicine, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
MD, MHAEli Magen
1Leumit Research Institute & Department of Family Medicine, Leumit Health Services, Israel
4Medicine C Department, Clinical Immunology and Allergy Division, Barzilai University Medical Center, Ben Gurion University of the Negev, Israel
MD![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
Data were obtained from patients' electronic health records, and IRB approval restrains its use to researchers inside Leumit Health Services.
Posted August 22, 2021.
Large-scale study of antibody titer decay following BNT162b2 mRNA vaccine or SARS-CoV-2 infection
Ariel Israel, Yotam Shenhar, Ilan Green, Eugene Merzon, Avivit Golan-Cohen, Alejandro A Schäffer, Eytan Ruppin, Shlomo Vinker, Eli Magen
medRxiv 2021.08.19.21262111; doi: https://doi.org/10.1101/2021.08.19.21262111
Now published in Vaccines doi: 10.3390/vaccines10010064
Subject Area
Subject Areas
- Addiction Medicine (407)
- Allergy and Immunology (718)
- Anesthesia (213)
- Cardiovascular Medicine (3030)
- Dermatology (256)
- Emergency Medicine (453)
- Epidemiology (12948)
- Forensic Medicine (12)
- Gastroenterology (845)
- Genetic and Genomic Medicine (4755)
- Geriatric Medicine (438)
- Health Economics (745)
- Health Informatics (3018)
- Health Policy (1091)
- Hematology (405)
- HIV/AIDS (950)
- Medical Education (448)
- Medical Ethics (118)
- Nephrology (488)
- Neurology (4529)
- Nursing (241)
- Nutrition (669)
- Oncology (2352)
- Ophthalmology (665)
- Orthopedics (262)
- Otolaryngology (332)
- Pain Medicine (294)
- Palliative Medicine (85)
- Pathology (511)
- Pediatrics (1226)
- Primary Care Research (513)
- Public and Global Health (7118)
- Radiology and Imaging (1579)
- Respiratory Medicine (939)
- Rheumatology (456)
- Sports Medicine (395)
- Surgery (502)
- Toxicology (63)
- Transplantation (217)
- Urology (187)